CytomX Therapeutics
CTMX
CTMX
109 hedge funds and large institutions have $400M invested in CytomX Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 29 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 113 → 109 (-4)
Holders
109
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.35M | |
| 2 | +$7.58M | |
| 3 | +$4.32M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$3.71M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.91M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.15M | |
| 3 | -$6.57M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.05M |
| 5 |
First Manhattan
New York
|
-$3.46M |